Received Feb 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Hypocalcemia; This serious case was reported by a other health professional via sales rep and described the occurrence of hypocalcemia in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced hypocalcemia (Verbatim: Hypocalcemia) (serious criteria hospitalization). The outcome of the hypocalcemia was resolved. It was unknown if the reporter considered the hypocalcemia to be related to Shingrix. The company considered the hypocalcemia to be unrelated to Shingrix. Additional Information: GSK receipt date: 28-JAN-2025 Other HCP reported that patient was in hospital for Hypocalcemia from unknown date. Expiry Date of Shingrix were not known. Reporter did not know whether it was 1st or 2nd dose of Shingrix.; Sender's Comments: Hypocalcaemia is an unlisted event which is considered unrelated to GSK vaccine Shingrix.